New Book Urges Use of Antidepressants to Treat, Prevent Cancer

“Killing Cancer” by Dr. Julian Lieb reviews medical research showing that antidepressants have potent anticancer properties.

More than 120 clinical, laboratory, and epidemiological studies illuminate the anticancer properties of antidepressants. Antidepressants kill cancer cells, inhibit their proliferation, protect nonmalignant cells from damage by ionizing radiation and chemotherapy toxicity, convert multidrug resistant cells to sensitive, and target the mitochondria of cancer cells while sparing those of healthy ones.

Depression significantly increases the risk of cancer, and increases and accelerates its mortality. Antidepressants are capable of arresting cancer even in advanced stages, and occasionally eradicating it.

Published reports to date reveal that antidepressants are potentially effective for such treatment resistant malignancies as cancer of the lungs, kidneys, and liver, malignant gliomas of the brain, and inflammatory breast cancer. Lieb points out that the use of relatively inexpensive antidepressants could make cancer treatment available to low-income and disadvantaged segments of the population. By slashing the cost of cancer care, antidepressants could energize health reform and economic recovery.

“Great advances seldom emanate from ivory tower medical schools or government health agencies,” Lieb says. “They are often made by outsiders that draw together observations whose relationship to each other had never been suspected.”

In making the case for antidepressants, Lieb discusses prostaglandins, molecules that regulate the physiology of every cell in the body. When produced above a critical threshold, prostaglandins can cause many disorders including depression and cancer. By inhibiting the production of prostaglandins, antidepressants can defeat cancer. Cancer is not a hundred different diseases, as touted, but one disease with innumerable variations.

“Killing Cancer” is available for sale online at Amazon.com and other channels.

About the Author

Dr. Julian Lieb is a retired Yale School of Medicine professor, and author or co-author of 48 published articles and 11 books, Lieb is a recognized expert on the immunostimulating and antimicrobial properties of lithium and antidepressants, and the anticancer properties of antidepressants. He has worked closely with pioneers in prostaglandin research, and has been invited to address international cancer conferences in Greece, Germany and India.

* For educational purposes only.

* May be verified by accessing Pubmed, and entering “antidepressants” and “cancer.”

In terms of human and ethical rights, and my professional responsibility, you are required to disseminate this information as widely as possible, without reevaluation, interference or delay, a right that is enshrined in a hundred constitutions worldwide. Secondly, how possibly could a cancer innovation crucial to the survival of humanity be copyrighted?

Hot this week

Did David Wineland and Serge Haroche Steal Idea For The Nobel Physics Prize?

Dr. Omerbashich says the Royal Swedish Academy is a Crime Scene and he has the proof that Nobel laureates stole his discovery.

New Approaches to Disaster Relief Challenges

Disaster relief has always been a challenge. NASA, Google,...

3 Legitimate Money Making Methods to Supplement Your Income

In a perfect world, when your landlord raises your...

2016 Predictions by World Renowned Medium and Psychic Lindy Baker

World renowned medium and psychic Lindy Baker is interviewed by The Hollywood Sentinel, discussing psychic power, the spirit world, life after death, areas of concern in 2016, and much more.

Digital Coupon Customers Spending More Than Double At Stores

A new study shows that customers who use digital coupons go shopping more for groceries and other household goods more often and spend more on their shopping trips.

The Checkup Men Skip: What Testicular and Prostate Warning Signs Actually Look Like

Men are remarkably good at tolerating discomfort and remarkably bad at reporting it. Ask a urologist what the most common delay in genitourinary cancer care looks like, and the answer is rarely a diagnostic failure. It is a man who noticed

The Research Report Passed Review, but the Evidence Was Incomplete: Why Biotechnology Companies Need Stronger Scientific Audit Trails

A biotechnology company receives a laboratory report that appears to confirm a research finding. The figures are consistent, the document has been reviewed, and the reported result seems sufficient to support the next stage of an investigat

What to Expect at Your First Pointe Shoe Fitting

For all young dancers who take even a single...

The Insurer’s Nurse Followed You Into the Exam Room

You're on the paper-covered exam table waiting for the orthopedist when someone you've never met walks in behind the nurse. She introduces herself as the case manager assigned to your workers' compensation claim, takes the chair by the door

When the Second Assist Vanishes, Who Carries the Exposure?

A lumbar fusion requires more than the surgeon's hands. Retractors must maintain exposure, instruments need to move efficiently, and the team must respond when bleeding or difficult anatomy changes the operative plan. In some operating room

I Tested Stop Brain Clutter App’s Personalized Meditation System

Stop Brain Clutter takes a different approach to guided meditation. The app builds a personalized meditation from information you give it.

Israel, You Must Muster Unity

But what makes Israel particularly remarkable is the idea that unity does not require sameness.

Related Articles

Popular Categories